Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07708116 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

First in Human Trial of CTX-187 in Healthy Volunteers and Chronically Infected Patients

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The primary objective of this trial is to assess the safety and tolerability of single and multiple ascending intravenously (IV) infused doses of CTX-187 when administered to healthy adult male and female participants and participants with a bacterial infection (bronchiectasis participants chronically infected with P. aeruginosa).
Trial Details
NCT Number NCT07708116
Lead Sponsor Centauri Therapeutics Limited
Conditions
(from sponsor)		 Bronchiectasis Adult, Bronchiectasis With Pseudomonas Aeruginosa Colonization, Bacterial Infections
Related terms Bacterial Infections, Bronchiectasis, Pseudomonas Infections
Enrollment 104 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov